Kennedy VE, Touya M, Spalding J, Young C, et al. Real-world treatment adherence and persistence of FLT3 inhibitors as post-alloHCT maintenance therapy in patients with AML in the United States: a cohort study using administrative claims data. Leuk Lymphoma 2025;66:2697-2707.
PMID: 41041900